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Abstract
Background: Innovative strategies are required to improve access to evidence-based tinnitus interventions. A
guided Internet-based cognitive behavioural therapy (iCBT) intervention for tinnitus was therefore developed
for a U.K. population. Initial clinical trials indicated efficacy of iCBT at reducing tinnitus severity and associated
comorbidities such as insomnia and depression. The aim of this phase III randomised controlled trial is to compare
this new iCBT intervention with an established intervention, namely face-to-face clinical care for tinnitus.
Methods/design: This will be a multi-centre study undertaken across three hospitals in the East of England. The
design is a randomised, two-arm, parallel-group, non-inferiority trial with a 2-month follow-up. The experimental
group will receive the guided iCBT intervention, whereas the active control group will receive the usual face-to-face
clinical care. An independent researcher will randomly assign participants, using a computer-generated
randomisation schedule, after stratification for tinnitus severity. There will be 46 participants in each group. The
primary assessment measure will be the Tinnitus Functional Index. Data analysis will establish whether non-
inferiority is achieved using a pre-defined non-inferiority margin.
Discussion: This protocol outlines phase III of a clinical trial comparing a new iCBT with established face-to-face
care for tinnitus. If guided iCBT for tinnitus proves to be as effective as the usual tinnitus care, it may be a viable
additional management route for individuals with tinnitus. This could increase access to evidence-based effective
tinnitus care and reduce the pressures on existing health care systems.
Trial registration: ClinicalTrials.gov identifier: NCT02665975. Registered on 22 January 2016.
Keywords: Service development, Tinnitus management, Clinical intervention, Tinnitus distress, Non-inferiority trial,
Tinnitus treatment, Internet intervention, Cognitive behavioural therapy, Guided intervention
Background
Tinnitus is a complex phenomenon characterised by
sounds that are consciously perceived in the absence of
an external sound source [1]. Owing to the heterogeneity
of tinnitus, pharmacological and medical treatments are
often unsuccessful, and a cure is still being sought [2].
Experiencing tinnitus may negatively affect many aspects
of daily life, including sleep, mood and concentration
[3]. It can therefore be debilitating and reduce quality of
life. Attending specialised tinnitus clinics may signifi-
cantly reduce functional and social disability related to
tinnitus. Audiological professionals frequently provide
this care. They play a major role in offering support to
patients experiencing tinnitus. This is largely due to the
relationship between tinnitus and hearing loss, although
tinnitus can occur without hearing loss [4]. Tinnitus
clinics in the United Kingdom are encouraged to provide
tinnitus management in line with good practice guidelines
[5]. Recommended management approaches include
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informational counselling, patient education, sound ther-
apy, relaxation therapy, sleep management, the fitting of
hearing aids or wearable sound generators, and the use of
cognitive behavioural therapy (CBT). Audiology depart-
ments in the United Kingdom vary regarding which of
these services they offer and often use a combination of
approaches [6]. Research supporting the effectiveness of
many of these interventions in isolation is limited or ham-
pered by poor methodologies. There is, however, a wide
range of research supporting the efficacy of CBT in redu-
cing tinnitus distress [7, 8]. In addition, CBT has been
shown to reduce the effects of a range of conditions,
such as insomnia, anxiety, depression and pain [9]. It
is a practical solution-focused therapeutic approach
aimed at modifying unhelpful thought patterns in
order to promote tinnitus habituation [10]. CBT for tin-
nitus is a comprehensive programme encompassing ap-
plied relaxation, cognitive restructuring, and addressing
emotional reactions and problems related to having tin-
nitus [11]. A structured approach is recommended which
includes goal setting, active participation and relapse pre-
vention. Of interest is that both efficacy research and pa-
tient experience have indicated CBT to be of value as a
tinnitus intervention. Informational counselling and CBT
were rated more effective than the use of sound therapy
and fitting of hearing aids or sound generators by patients
attending one audiology department in England [12].
Although tinnitus interventions are of value, they may
be extensive, and encompass referrals to various disci-
plines [13]. The cost of tinnitus to the National Health
Service (NHS) in England is estimated to exceed £4.9 mil-
lion annually to cover only the initial general practitioner
(GP) appointment and one outpatient appointment [14].
This does not account for additional assessments, proce-
dures, prescriptions or referrals that are often required.
The economic costs of tinnitus are therefore substantial.
Further concerns are that not everyone with significant
tinnitus has access to these specialist services [6]. Many of
the estimated 750,000 people making GP appointments
every year in England with tinnitus as the primary com-
plaint are never referred for any specialist tinnitus care
[15]. In addition, the global burden of tinnitus appears to
be on the increase [14]. A possible reason is a rise in pro-
fessional and leisure-related noise exposure, which com-
prise one of the greatest risk factors for developing
tinnitus [16]. This increase is likely to place further con-
straints on health care systems that are already strained.
Innovative planning is required to ensure that systems are
able to meet these additional pressures. The use of
Internet-based cognitive behavioural therapy (iCBT) has
been incorporated into regular care in Europe to address
these demands [17, 18]. Because no such management
route is available in the United Kingdom, an iCBT inter-
vention was developed for those with tinnitus in the
United Kingdom [19], using the CBT content published
by Kaldo and colleagues [20]. A three-phase clinical trial
was designed to evaluate this intervention. One of the
aims was to establish whether an audiologist could guide
iCBT, in contrast to a clinical psychologist, who delivered
previous iCBT trials. The initial pilot study indicated the
feasibility and acceptability of this intervention in terms of
recruitment, compliance, attrition rates and use of audio-
logical support [21]. Phase II was a delayed treatment
efficacy randomised controlled trial [22]. Undertaking the
iCBT intervention led to a significant reduction in tinnitus
severity (Cohen’s d = 0.69) as measured by the Tinnitus
Functional Index (TFI) [23]. In addition, a reduction in
many of the comorbidities often associated with tin-
nitus, such as insomnia, depression and hyperacusis,
and an improvement in life satisfaction after undertak-
ing the intervention were found. These results
remained stable 2 months post-intervention. What is
unknown is how outcomes using this new iCBT inter-
vention compare with those of established face-to-face
(F2F) clinical care for tinnitus in the United Kingdom.
This article describes a study protocol to compare these
interventions.
Methods/design
Study objectives
The primary aim of this study will be to evaluate
whether iCBT for tinnitus is at least as effective as estab-
lished F2F care in reducing tinnitus severity. The key
secondary objective is to compare the effects of these
interventions for tinnitus-related comorbidities such as
insomnia, depression and anxiety. A further objective is
to assess stability of results 2 months post-intervention.
Another aim is to establish whether there are any pre-
dictor variables associated with outcomes for iCBT com-
pared with those for the usual F2F care. The hypothesis
is that iCBT is not inferior to F2F care and that effects
will be stable over the follow-up period.
Study design
A randomised, multi-centre, two-arm, parallel-group,
non-inferiority trial with a sequential adaptive design
and a 2-month follow-up will be conducted. The experi-
mental intervention, namely guided iCBT, will be com-
pared directly with an active control group, namely
usual individual F2F audiological care, as shown in the
Consolidated Standards of Reporting Trials (CONSORT)
flow diagram [24] in Fig. 1.
This study protocol is described using the Standard
Protocol Items: Recommendations for Interventional
Trials (SPIRIT) checklist [25, 26], which is included in
Additional file 1.
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Study population
Recruitment
The investigational sites were selected from among sites
partnered in the East of England Tinnitus Network to
improve consistency of practise across sites. To increase
chances of achieving the target sample size, three Eng-
land based primary care hospitals were selected, namely
Norfolk and Norwich Universities Hospitals Trust,
Milton Keynes University Hospital NHS Foundation
Trust and Hinchingbrooke Health Care NHS Trust,
which all have reputable clinical tinnitus services. The
study sponsor and central trial management centre is at
Anglia Ruskin University, Cambridge, UK. All adult pa-
tients referred to the participating tinnitus clinics during
the recruitment period who meet the inclusion criteria
will be invited to participate.
Inclusion criteria
Participant eligibility for the study is as follows:
1. Aged 18 years or older, living in the United
Kingdom and having the ability to read and type
in English
2. Regular access to a computer and the Internet and
the ability to use these
3. Examined clinically by an ear, nose and throat
(ENT) specialist and an audiologist to rule out any
medical causes for tinnitus. This evaluation would
typically include a case history, otoscopy,
tympanometry, hearing test and, where indicated,
magnetic resonance imaging.
4. Referred to the tinnitus clinic by an ENT specialist
or audiologist because of troublesome tinnitus.
Standard protocols will be followed whereby this
decision will have been made on the basis of the
presenting symptom profile and not on the use of a
tinnitus assessment measure.
Exclusion criteria
Exclusion criteria are as follows:
1. Reporting any major medical, psychiatric or mental
disorder which may hamper commitment to the
programme
2. Undergoing any tinnitus therapy concurrently to
partaking in this study
Enrolment and randomisation
Patients who satisfy the eligibility criteria following the
screening process will be enrolled and randomised in a
1:1 ratio to either intervention arm by an independent
research assistant using a computer-generated random-
isation schedule, after stratification for tinnitus severity.
Variable, randomly permuted block sizes of 4 and 6 will
be used. Whilst a blinded design would be optimal, in
this context it is not feasible. Participants allocated to
the experimental group will receive the guided iCBT
intervention, whereas those in the active control group
will receive care at their local hospital. Both participants
and the clinicians will therefore know the group alloca-
tion. The data analyst will, however, be masked during
data analysis. Following allocation, participants will be
contacted by the central research team to be informed
of the group to which they have been randomised and
when their treatment will commence.
Withdrawal/discontinuation of participants
Strategies to improve adherence to the intervention
protocols and minimise attrition rates will be applied as
recommended by Dziura and colleagues [27]. These in-
clude data collection not requiring clinical appointments
and the provision of regular, guided contact during the
trial. Participation is voluntary with the right to with-
draw without penalty. In rare cases, participants will be
withdrawn if, owing to unforeseen circumstances, they
are no longer able to participate. Reasons for withdrawal
will be recorded.
Assessment measures
Self-reported assessment measures are used in clinical
practice to quantify tinnitus severity and the presence of
other psychological conditions. These will therefore be
utilised to measure intervention effect, as shown in
Table 1. Online questionnaire delivery will be applied con-
sistently throughout the study for both groups. The same
questionnaires used in phases I and II of this clinical trial
will be utilised to maintain consistency, with the addition
of the Tinnitus Handicap Inventory (THI) [28]. A non-
Fig. 1 Consolidated Standards of Reporting Trials (CONSORT) study
flow diagram. F2F Face-to-face, iCBT Internet-based cognitive
behavioural therapy
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validated demographic questionnaire will be used to estab-
lish health-related and tinnitus-specific information. Per-
mission has been obtained to use the assessment
measures as required.
Primary assessment measure
The TFI [23] has been selected as the primary assess-
ment measure because of its validation for assessing
intervention responsiveness. The THI [28] will also be
administered for comparative purposes because this is
the most commonly used assessment measure in clinics
in the United Kingdom and is frequently used in clinical
trials [29].
Secondary assessment measures
Assessment measures related to areas which may be
affected by tinnitus have been selected as follows:
1. Sleep difficulties and associated worries about sleep
are prevalent amongst those with tinnitus. The
Insomnia Severity Index [30] will be included to
assess sleep duration, quality of sleep and the impact
of sleep habits on well-being.
2. The prevalence of anxiety and depression is high in
those with severe tinnitus [31]. To quantify these
levels, we will incorporate the Patient Health
Questionnaire [32] to measure depression severity
and the Generalised Anxiety Disorder [33] to assess
anxiety severity.
3. Owing to the large overlap in the prevalence of
tinnitus and a reduced tolerance of everyday sounds
[34], otherwise known as hyperacusis, the
Hyperacusis Questionnaire [35] will be administered.
4. Those with distressing tinnitus often find it difficult
to focus on other sounds or conversations because
of the penetrating nature of their tinnitus. The
Hearing Handicap Inventory for Adults-Screening
Version [36] will therefore be administered.
5. Tinnitus impairs cognitive function because of its
impact on the control of attention [37]. To assess
proneness to committing cognitive slips and errors
in the completion of everyday tasks, such as failures
in perception, memory and motor function, the
Cognitive Failures Questionnaire [38] will be
included.
6. To include an appropriate measure of the quality of
life of those with tinnitus, as opposed to self-care
and mobility, the Satisfaction With Life Scale [39]
was selected to assess global life satisfaction.
Weekly assessment measure
Participants will be monitored weekly using the Tinnitus
Handicap Inventory-Screening Version (THI-s) [40], a
concise measure consisting of ten questions. During
Table 1 Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) guideline schedule of enrolment, interventions
and assessments for both intervention groups
Study period Enrolment Intervention Post-intervention Follow-up
Measurement time point T0 (baseline) Lasting 2 months
on average
T1 (2–3 months
after baseline)
T2 (2 months
post- intervention)
Enrolment
Informed consent X
Online screening questionnaire X
Telephone screening X
Intervention allocation X
Assessments
Tinnitus Functional Index X X X
Tinnitus Handicap Inventory X X X
Insomnia Severity Index X X X
Patient Health Questionnaire X X X
Generalised Anxiety Disorder X X X
Hyperacusis Questionnaire X X X
Hearing Handicap Inventory X X X
Cognitive Failures Questionnaire X X X
Satisfaction with Life Scale X X X
Tinnitus Handicap Inventory-Screening Version Weekly for 8 weeks
Post-intervention telephone call X
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previous trials using this iCBT intervention for tin-
nitus, researchers found that tinnitus severity de-
creased on a weekly basis [21]. Once participants
reached the fourth week of the intervention, their
scores were significantly lower than their baseline
scores. It is hypothesised that this will again be the
case for the iCBT group in the present study. For
those undergoing the F2F intervention, this reduction
may occur at an earlier time point, owing to the more
intense nature of their initial care.
Assessment measurement schedule
All assessment measures will be collected online for
both groups using the following measurement schedule:
 Pre-intervention baseline measurements (T0):
Baseline measurements will be collected following
study registration and prior to allocation.
 Weekly assessment measurements (during
intervention): Whilst in the intervention phase, both
groups will be monitored for an 8-week period by
means of the THI-s. Participants from both groups
will be in active intervention for an average duration
of 2 months, although there may be some individual
variation from this. Those allocated to the iCBT ex-
perimental group will start the iCBT intervention
following allocation. Those in the active F2F control
arm will commence hospital-based intervention in
the first available clinical opening, typically 1–4
weeks post-allocation.
 Post-intervention measurements (T1): Data will be
collected post-intervention, typically 2–3 months
following baseline data collection. The same assess-
ment measures administered at baseline will be
completed.
 Follow-up intervention measurements (T2): Follow-
up data will be collected 2 months post-intervention
to determine the stability of intervention effects at
this time point.
The specific assessment measures for each collection
point are shown in Table 1. To improve attrition rates at
follow-up, e-mail reminders will be sent to encourage
participants to complete the questionnaires.
Semi-structured interviews
Participants who complete the online screening will be
contacted telephonically by the central research team.
These interviews will be recorded and transcribed for
qualitative analysis. They will provide the opportunity to
ask about participants’ expectations and motivations.
They will also offer the chance to discuss aspects of the
study and answer any questions. This initial contact has
been found to be valuable in ensuring participants are
motivated to complete the programme [41]. After com-
pletion of the post-intervention questionnaire, partici-
pants will be telephoned again to discuss their progress
and find out more about their experiences during
participation.
Study interventions
The following intervention groups will be running in
parallel:
 The experimental iCBT group, which will receive the
iCBT intervention over an 8-week period
 The F2F active control group, which will be under
the care of their local hospital for an average
duration of 8 weeks and attend an average of two
or three appointments
Intervention outline for both groups
 The estimated duration of active intervention is an
8-week period for both groups, although some
individual variation may occur.
 Information about managing tinnitus will be
provided to both groups. The delivery of this
information will differ, however, being provided
online for the iCBT group and F2F for the active
F2F control group.
 A log will be kept of the information provided to
individuals in both groups. This will be the modules
actually done by the iCBT group participants and
content covered during appointments for individuals
in the F2F group.
 During the initial clinical examination, all
participants will be assessed regarding their
suitability for hearing aids or combination devices.
Where indicated, these will be provided regardless
of group allocation.
 An audiologically trained professional will support
both groups. This may be a hearing therapist,
audiologist or clinical scientist in audiology. Criteria
for inclusion of clinicians (providing the intervention
to both groups) will be to have had training and
experience in managing patients with tinnitus, to be
part of a professional tinnitus network and to
maintain good clinical practice. In this way, the
interventions provided were standardised as much
as possible despite participants’ attending different
hospitals. The clinicians also agreed to abide by a
structured protocol in order for similar components
to be received by all participants.
Guided iCBT intervention outline (experimental group)
The experimental group will commence the iCBT inter-
vention following group allocation. The CBT content is
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based on a self-help programme (iCBT) originally devel-
oped by Andersson and colleagues [20, 42]. The focus of
this intervention is to address the physical, emotional and
problematic effects of experiencing tinnitus to aid habitu-
ation to tinnitus. Key audiological principles, such as the
use of sound enrichment, are also incorporated into the
programme. The content of the original programme has
been redeveloped for a U.K. population into an interactive
e-learning version to ensure that it is visually stimulating,
engaging and responsive to participant’s progress [19].
The intervention is partly tailored to individual needs and
consists of 16 recommended modules and 5 optional
modules, as shown in Table 2. Modules will be released
on a weekly basis over an 8-week period. Participants will
be instructed to engage with the modules and then
practise the suggested techniques on a daily basis. The
programme is therefore comprehensive, offering a range
of key CBT techniques to maximise behaviour change.
The information can be read online, downloaded to be
read offline, or printed. The modules contain a mixture of
information, videos, quizzes, diagrams, suggested tech-
niques to apply in daily life, worksheets to keep track of
progress, and solutions for common problems. There is a
secure messaging system to enable participants to ask
questions and allow their assigned audiologists to provide
feedback.
Face-to-face intervention outline (active control
intervention)
The F2F group will receive F2F individualised therapy
for tinnitus using the usual informational counselling ap-
proach generally followed in the management of tinnitus
in the United Kingdom. A structured protocol including
similar intervention components was developed to
standardise the care received across the different hospi-
tals, as seen in Table 3. This content will, however, be
tailored to each individual. The initial appointment will
generally be used to provide explanations about tinnitus
and the effects thereof on the individual’s day-to-day life
and provide some basic management strategies. A
follow-up appointment will be made for 1 month later
to discuss additional strategies for tinnitus management.
One month later a second follow-up appointment may
be made to further address remaining difficulties. These
appointments will last 60 minutes, on average, although
they may be shorter for those not requiring as much
Table 2 Weekly guided Internet-based cognitive behavioural therapy intervention modules for the experimental group
Time line Intervention content Intervention load
Weekly reading Daily practising
Week 1 Programme rational and outline 15 minutes
Understanding tinnitus 15 minutes
Week 2 Deep relaxation 10 minutes 10 minutes
Positive imagery 10 minutes 5 minutes
Sound enrichmenta 10 minutes As required
Week 3 Diaphragmatic breathing 10 minutes 10 minutes
Reinterpreting tinnitus 10 minutes 5 minutes
Sleep managementa 15 minutes As required
Week 4 Entire body relaxation 10 minutes 5 minutes
Focussing techniques 10 minutes 5 minutes
Concentration managementa 10 minutes As required
Week 5 Rapid relaxation 10 minutes 3 minutes
Thought analysis 15 minutes 3 × 15 minutes
Reducing sound sensitivitya 15 minutes Daily
Week 6 Relaxation in daily routines 10 minutes 3–5 situations
Cognitive restructuring 15 minutes 3 × 15 minutes
Communication tacticsa 15 minutes As required
Week 7 Relaxation in stressful situations 10 minutes As required
Exposure to tinnitus 10 minutes 3 × 5 minutes
Week 8 Reviewing helpful techniques 20 minutes Evaluation
Maintenance and relapse prevention 20 minutes Future plan
aOptional modules to be done if required
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input. The total time under active intervention will be 2
months, on average.
Safety and clinical monitoring
Protocols to minimise the risks to participants and the
researcher have been put in place. The data, together
with any other spontaneously reported adverse events
during the intervention, will be reported. If any partici-
pants are identified as requiring additional support, a
letter will be provided for them to take to their GP so
that this care can be arranged.
Participants in the iCBT experimental group will be
monitored by the audiologist evaluating their worksheets
and with communications via a secure online messaging
system. This therapeutic alliance will allow for feedback
and assistance if participants have any difficulties. Partic-
ipants in the F2F group will be monitored by the audi-
ology professional they see.
In addition, all participants will be monitored on a
weekly basis during the course of the study by means of
the THI-s. If a participant’s scores suddenly worsen, the
participant will be appropriately managed.
Data management
The central electronic online data-capturing system is
held in Linköping University (Sweden) because of their
expertise in Internet interventions. The web portal has
appropriate policies and procedures in place complying
with the following U.K. legislation: the Data Protection
Act [43] and the Privacy and Electronic Communica-
tions (EC Directive) Regulations [44]. Appropriate tech-
nical and organisational measures have been taken to
safeguard the security of the web portal; the servers are
located in a locked computer room to which only
authorised personnel have access by using cards and
keys. It is also not possible to establish a link between
the data and individual users through access to the
database. Data will be kept on the secure web portal.
Data exported for statistical analysis will be kept for 1
year following the end of the study at http://www.data-
archive.ac.uk/ and then destroyed following this point.
All personal data will be kept confidential. Each partici-
pant will be assigned a random user code (four digits
followed by four letters). This will be used by clinicians to
identify the participant during the trial. All data communi-
cation between servers and users are encrypted (via TLS/
https), and all sensitive data will be stored encrypted in
the database, using algorithms such as hash message au-
thentication code/secure hash algorithm 256/secret keys.
The researchers, statisticians and internal data moni-
toring committee will have access to the final dataset.
They will ensure accurate analysis and results interpret-
ation. The sponsor of the study will have no role in the
study design, data collection, data analysis, data inter-
pretation or writing of the report.
Data analysis
Data analysis will be performed in accordance with CON-
SORT guidelines for randomised clinical trials [24, 45].
IBM SPSS Statistics version 23.0 software (IBM, Armonk,
NY, USA) [46] will be used for quantitative analysis, and
the data analyst will be masked to the groups to minimise
bias. The statistical analysis will test the null hypothesis of
the non-inferiority of iCBT compared with F2F clinical
care between baseline and post-intervention.
Non-inferiority margin
A fundamental principle in the analysis of non-
inferiority trials is establishing the non-inferiority margin
for analysis [45]. To our knowledge, there are no non-
inferiority trials using the TFI as the primary assessment
measure. Because there is no established margin, this
was set using both statistical reasoning and clinical judg-
ment. When developing the TFI, the authors reported
Table 3 Face-to-face intervention content for the control group
Timeline Intervention content to be individually tailored and may include Intervention load
Explanation Daily practising
Initial appointment In-depth case history 20 minutes
Information about tinnitus 20 minutes
Sound enrichment advice and equipment demonstration 20 minutes As required
Follow-up appointment Recap 5 minutes
Relaxation advice 15 minutes 10 minutes
Sleep management advice 20 minutes As required
CBT techniques such as identifying negative automatic thoughts 20 minutes As required
Second follow-up appointment Review difficulties and address these 20 minutes As required
Advice on further support (e.g., tinnitus support groups, charities, tinnitus apps) 20 minutes As required
Further options (e.g., mindfulness, hypnosis or concentration management) 20 minutes As required
CBT Cognitive behavioural therapy
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that a 13-point difference was considered a clinically sig-
nificant change in score [23]. Further studies using the
TFI have reported larger differences. Fackrell et al. [47],
for instance, suggested 22.4 points to be a significant
change in score. Using clinical judgment, differences
greater than 13 points would not be classed as clinically
non-significant. A 13-point non-inferiority margin was
judged to be the most reasonable both statistically and
clinically.
Sample size
The SampSize app using a non-inferiority parallel group
assisted with sample size calculations [48]. The α was set
to 0.025, power at 90%, and the non-inferiority margin
to 13 points with a slightly larger SD of 17 points. The
minimal sample size for each group is 39 participants.
An additional seven participants will be assigned to each
group to account for possible dropouts, estimated on
the basis of previous trials of a similar nature to be be-
tween 10% and 20% [17, 18]. Therefore, 46 participants
will be recruited in each arm.
Group differences
Baseline group differences will be analysed using inde-
pendent samples t tests for continuous variables and
chi-square tests for categorical variables. In accordance
with the recommendations for non-inferiority trials
[45, 49], analysis of the primary assessment measure
will follow a per-protocol analysis. Participants will be
analysed on a per-protocol basis if they complete the
post-intervention assessment measures. In addition,
per-protocol results will be compared with those using
an intention-to-treat paradigm. To enable intention-to-
treat analysis, missing value analysis will be done, in-
cluding Little’s missing completely at random test [50]
to test for the missing completely at random assump-
tion. If appropriate, missing data will be imputed
through the multiple imputation procedures offered by
IBM SPSS Statistics software using the Markov chain
Monte Carlo method with five imputation runs [51].
All baseline assessment measure results will be used as
predictors.
To determine whether iCBT is at least as effective as
F2F care, a confidence interval approach will be used.
Non-inferiority of iCBT compared with F2F care will be
established if the lower limit of the two-sided 95% confi-
dence interval of the mean difference between these two
interventions is less than the non-inferiority margin of
13 points. Owing to the non-inferiority trial, one-sided
investigations with a significance of 0.025 will be used.
Regression analysis will be used to determine if there is
a relationship between baseline and outcome variables in
an attempt to identify predictor variables.
Qualitative analysis
The open-ended questions in the screening and the
semi-structured telephone conversations will be analysed
using NVivo 10 software (QSR International, Melbourne,
Australia) [52]. The theoretical framework for qualitative
analysis will be qualitative content analysis [53].
The study results will be shared in peer-reviewed
publications by the present authors and presented at re-
search conferences. A summary of the findings will be
available to study participants as well as to members of
tinnitus support and tinnitus charity groups.
Public-patient partnership
This study is designed to let the general public, clinicians
and researchers work together in creating an opportunity
for a new scientific and clinical intervention. Involvement
of a service public-patient partnership is included in this
study. A public-patient partnership has been engaged in
this research since the development stage and assisted
with functionality testing and evaluation of the developed
iCBT intervention. This partnership has had input into
the study design and study materials used to ensure they
are patient-friendly. This group will also serve as an
independent point of contact for participants for impartial
advice about the study.
Discussion
In view of the present health care burden of tinnitus, to-
gether with estimates that the incidence of tinnitus may
only increase, an innovative Internet-based intervention
for tinnitus (iCBT) has been developed. Having an add-
itional intervention available for triage may free clinical
appointments for those with the greatest need and provide
care for those who have limited access to clinical care for
geographical or health-related reasons. The feasibility and
efficacy of iCBT in the United Kingdom has been estab-
lished [21, 22]. What has not been determined, however, is
how this intervention compares with that of the usual care
for tinnitus (i.e., F2F intervention). A strength of this study
is that it builds on previous studies by determining feasi-
bility and efficacy in a controlled and powered manner. A
further strength is its randomised design, including out-
come measures for both tinnitus and possible comorbidi-
ties and a follow-up assessment to establish maintenance
effects of both interventions.
Studies in Europe that compared iCBT against F2F
group interventions reported similar results, regardless
of the format of the intervention provided [17, 18, 41].
This study builds on previous research by using an audi-
ologist instead of a clinical psychologist to present the
iCBT intervention. Establishing whether audiological
professions are able to run an iCBT intervention using
their audiological background in tinnitus is important
because this is the group of professionals who treat
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tinnitus in the United Kingdom. This trial is furthermore
unique in that it compares iCBTagainst individual F2F clin-
ical care, as opposed to a group-based approach used in
previous studies. The wide range of assessment measures
proposed to fully evaluate the effects of the interventions
on both tinnitus severity and its comorbidities is a strength
of this study. The information obtained will be valuable to
help determine for whom this may be a suitable form of
intervention, which is an important goal of this study.
The trial has been carefully designed to maximise
participant retention by use of regular contact and com-
pletion of assessments online. The intervention itself is
also in its third revision as improvements are made in a
continual manner following participant suggestions.
These improvements are envisioned to improve partici-
pant retention. The potential impact of this research is
significant in that it may provide more accessible tin-
nitus management options and reduce the burden on
current health care and costs of tinnitus-related services.
iCBT may be recommended for certain individuals with
tinnitus following their clinical examination.
Limitations of the study include the non-uniform nature
of clinical care, although attempts have been made to
standardise this care as far as possible. Potential barriers
may be low recruitment into the study owing to a prefer-
ence for F2F interventions and lower acceptance of
computerised interventions [54]. Publicity regarding the
previous research by both the researchers and those who
have undertaken the intervention will help improve re-
cruitment. Involvement of the public-patient partnership
may also help improve recruitment. A further barrier may
be that not all participants will have Internet access. Al-
though 87.9% of adults in the United Kingdom use the
Internet [55], this percentage decreases to 38.7% of adults
aged 75 years or older. A limitation of the study design is
that it is not possible to mask the researcher and partici-
pants during the intervention, so they will know in which
group they have been placed. Bias will be minimised, how-
ever, by masking during randomisation and data analysis.
If iCBT is shown to be an effective addition to the
usual tinnitus care in the management of tinnitus, fur-
ther research will be needed to determine the actual po-
tential of iCBT as a viable intervention. The research
will also be required to determine under which circum-
stances iCBT is effective. Determining participants’ per-
ceptions and experiences of both interventions, as well
as what may influence these factors, should also be the
focus of future studies. Results of this study are expected
to be available during 2018.
Trial status
Trial recruitment started in October 2016 and is esti-
mated to last until April 2017 (protocol version 6, dated
23 March 2017).
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Abbreviations
CBT: Cognitive behavioural therapy; CONSORT: Consolidated Standards of
Reporting Trials; ENT: Ear, nose and throat; F2F: Face-to-face; GP: General
practitioner; iCBT: Internet-based cognitive behavioural therapy;
NHS: National Health Service; SPIRIT: Standard Protocol Items:
Recommendations for Interventional Trials; THI: Tinnitus Handicap Inventory;
THI-s: Tinnitus Handicap Inventory-Screening Version; TFI: Tinnitus Functional
Index
Acknowledgements
We are grateful to the British Society of Audiology for funding this study with an
applied research grant. We extend our thanks to Linköping University for
hosting the web portal for this study and to their webmaster, George Vlaescu,
for technical assistance. We thank Norfolk and Norwich University Hospitals NHS
Foundation Trust, Hinchingbrooke Health Care NHS Trust and Milton Keynes
University Hospital NHS Foundation Trust for hosting this study. In particular, we
thank the clinical leads, namely Claire Gatenby, Julie Lloyd and Rachel Robinson.
We also thank the individuals involved in the public-patient partnership forum
for their assistance in this project.
Funding
Funding for this trial was kindly provided by the British Society of Audiology
through an applied research grant. The organisation had no role in the
design of the study or in the preparation or approval of the manuscript.
Availability of data and materials
See the SPIRIT checklist in Additional file 1.
Authors’ contributions
EWB designed the study protocol, was the major contributor in the writing
of the manuscript and was project manager for the operational aspects of
the study. DMB participated in conceiving and designing the study as well
as in some of the intervention materials and operational aspects. PMA
participated in conceiving and designing the study as well as in some
ethical aspects related to the study. VM participated in conceiving and
designing the study. GA participated in conceiving and designing the study
and in provision of the intervention infrastructure. All authors critically
revised as well as read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests. Anglia Ruskin,
Lamar and Linköping universities and the National Institute for Health Research
supported the undertaking of this study, but the views expressed are those of
the authors and not of these institutions.
Consent for publication
Consent for publication is obtained from all participants as part of the
informed consent process.
Ethics approval and consent to participate
Ethical approval has been granted by the East of England – Cambridge
South Research Ethics Committee (REC reference 16/EE/0148) and the Health
Research Authority (Integrated Research Application System project identifier
195565). The research and development departments of all participating
centres provided permission for the study to take place within the selected
hospitals. Participants provide informed consent online if they are interested
in participating. Any trial modifications will be communicated to all relevant
parties. The study sponsor is Prof. Michael Cole, Anglia Ruskin University
(michael.cole@anglia.ac.uk).
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Beukes et al. Trials  (2017) 18:186 Page 9 of 11
Author details
1Department of Vision and Hearing Sciences, Anglia Ruskin University,
Cambridge, UK. 2National Institute for Health Research [NIHR], Nottingham
Biomedical Research Centre, Ropewalk House, 113 The Ropewalk,
Nottingham, UK. 3Otology and Hearing Group, Division of Clinical
Neuroscience, School of Medicine, University of Nottingham, Nottingham,
UK. 4Vision and Eye Research Unit, Anglia Ruskin University, Cambridge, UK.
5Department of Speech and Hearing Sciences, Lamar University, Beaumont,
Texas, USA. 6Linnaeus Centre HEAD, Swedish Institute for Disability Research,
Department of Behavioural Science and Learning, Linköping University,
Linköping, Sweden. 7Audiology India, Mysore, Karnataka, India. 8Department
of Speech and Hearing, School of Allied Health Sciences, Manipal University,
Manipal, Karnataka, India. 9Department of Behavioural Sciences and Learning,
Linköping University, Linköping, Sweden. 10Division of Psychiatry,
Department of Clinical Neuroscience, Karolinska Institute, Stockholm,
Sweden.
Received: 13 July 2016 Accepted: 5 April 2017
References
1. Baguley D, Andersson G, McFerran D, McKenna L. Tinnitus: a
multidisciplinary approach. 2nd ed. Chichester: Wiley-Blackwell; 2013.
2. Beebe PD, Joos K, De Ridder D, Vanneste S. The management and
outcomes of pharmacological treatments for tinnitus. Curr Neuropharmacol.
2015;13(5):692–700.
3. Langguth B. A review of tinnitus symptoms beyond ‘ringing in the ears’: a
call to action. Curr Med Res Opin. 2011;27(8):1635-43.
4. Gander PE, Hoare DJ, Collins L, Smith S, Hall DA. Tinnitus referral pathways
within the National Health Service in England: a survey of their perceived
effectiveness among audiology staff. BMC Health Serv Res. 2011;11:162.
5. Department of Health. Provision of services for adults with tinnitus: a good
practice guide. London: Central Office of Information; 2009.
6. Hoare DJ, Broomhead E, Stockdale D, Kennedy V. Equity and person-
centeredness in provision of tinnitus services in UK National Health Service
audiology departments. Eur J Pers Cent Healthc. 2015;3(3):318–26.
7. Hesser H, Weise C, Westin VZ, Andersson G. A systematic review and meta-
analysis of randomized controlled trials of cognitive–behavioral therapy for
tinnitus distress. Clin Psychol Rev. 2011;31(4):545–53.
8. Grewal R, Spielmann PM, Jones SEM, Hussain SSM. Clinical efficacy of
tinnitus retraining therapy and cognitive behavioural therapy in the
treatment of subjective tinnitus: a systematic review. J Laryngol Otol. 2014;
128(12):1028–33.
9. Butler AC, Chapman JE, Forman EM, Beck AT. The empirical status of
cognitive-behavioral therapy: a review of meta-analyses. Clin Psychol Rev.
2006;26(1):17–31.
10. Hallam RS, Rachman S, Hinchcliffe R. Psychological aspects of tinnitus. In:
Rachman S, editor. Contributions to medical psychology, vol. 3. Oxford:
Pergamon; 1984. p. 31–53.
11. Andersson G. Psychological aspects of tinnitus and the application of
cognitive–behavioral therapy. Clin Psychol Rev. 2002;22(7):977–90.
12. Aazh H, Moore BC, Lammaing K, Cropley M. Tinnitus and hyperacusis therapy
in a UK National Health Service audiology department: patients’ evaluations of
the effectiveness of treatments. Int J Audiol. 2016;55(9):514–22.
13. Cima R, Joore M, Maes I, Scheyen D, El Refaie AE, Baguley DM, et al. Cost-
effectiveness of multidisciplinary management of tinnitus at a specialized
tinnitus centre. BMC Health Serv Res. 2009;9:29.
14. Martinez C, Wallenhorst C, McFerran D, Hall DA. Incidence rates of clinically
significant tinnitus: 10-year trend from a cohort study in England. Ear Hear.
2015;36(3):e69–75.
15. El‐Shunnar SK, Hoare DJ, Smith S, Gander PE, Kang S, Fackrell K, et al.
Primary care for tinnitus: practice and opinion among GPs in England. J Eval
Clin Pract. 2011;17(4):684–92.
16. Roberts LE, Eggermont JJ, Caspary DM, Shore SE, Melcher JR, Kaltenbach JA.
Ringing ears: the neuroscience of tinnitus. J Neurosci. 2010;30:14972–9.
17. Kaldo-Sandström V, Larsen HC, Andersson G. Internet-based cognitive-
behavioral self-help treatment of tinnitus: clinical effectiveness and
predictors of outcome. Am J Audiol. 2004;13(2):185–92.
18. Kaldo V, Haak T, Buhrman M, Alfonsson S, Larsen HC, Andersson G. Internet-
based cognitive behaviour therapy for tinnitus patients delivered in a
regular clinical setting: outcome and analysis of treatment dropout. Cogn
Behav Ther. 2013;42(2):146–58.
19. Beukes EW, Vlaescu G, Manchaiah V, Baguley DM, Allen PM, Kaldo V, et al.
Development and technical functionality of an Internet-based intervention
for tinnitus in the UK. Internet Interv. 2016;6:6–15.
20. Kaldo V, Cars S, Rahnert M, Larsen HC, Andersson G. Use of a self-help book
with weekly therapist contact to reduce tinnitus distress: a randomized
controlled trial. J Psychosom Res. 2007;63(2):195–202.
21. Beukes EW, Allen PM, Manchaiah V, Baguley DM, Andersson G. Internet-
based intervention for tinnitus: outcome of a single-group open trial.
J Am Acad Audiol. 2017;28(4):340–51.
22. Beukes EW, Manchaiah V, Allen PM, Baguley DM, Andersson G. Internet-based
cognitive behavioural therapy for adults with tinnitus in the UK: study protocol
for a randomised controlled trial. BMJ Open. 2015;5(9):e008241.
23. Meikle MB, Henry JA, Griest SE, Stewart BJ, Abrams HB, McArdle R, et al. The
Tinnitus Functional Index: development of a new clinical measure for
chronic, intrusive tinnitus. Ear Hear. 2012;33(2):153–76.
24. Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT 2010
statement: updated guidelines for reporting parallel group randomised
trials. BMC Med. 2010;8:18.
25. Chan A, Tetzlaff JM, Altman DG, Laupacis A, Gøtzsche PC, Krleža-Jerić K, et
al. SPIRIT 2013 statement: defining standard protocol items for clinical trials.
Ann Intern Med. 2013;158(3):200–7.
26. Chan A, Tetzlaff JM, Gøtzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT
2013 explanation and elaboration: guidance for protocols of clinical trials.
BMJ. 2013;346:e7586.
27. Dziura JD, Post LA, Zhao Q, Fu Z, Peduzzi P. Strategies for dealing with
missing data in clinical trials: from design to analysis. Yale J Biol Med. 2013;
86(3):343–58.
28. Newman CW, Jacobson GP, Spitzer JB. Development of the tinnitus
handicap inventory. Arch Otolaryngol Head Neck Surg. 1996;122(2):143–8.
29. Hall DA, Haider H, Szczepek AJ, Lau P, Rabau S, Jones-Diette J, et al.
Systematic review of outcome domains and instruments used in clinical
trials of tinnitus treatments in adults. Trials. 2016;17:270.
30. Bastien CH, Vallières A, Morin CM. Validation of the Insomnia Severity Index as
an outcome measure for insomnia research. Sleep Med. 2001;2(4):297–307.
31. Pinto PC, Marcelos CM, Mezzasalma MA, Osterne FJ, de Melo Tavares de
Lima MA, Nardi AE. Tinnitus and its association with psychiatric disorders:
systematic review. J Laryngol Otol. 2014;128(8):660–4.
32. Spitzer RL, Kroenke K, Williams JBW, Patient Health Questionnaire Primary
Care Study Group. Validation and utility of a self-report version of PRIME-
MD: the PHQ Primary Care Study. JAMA. 1999;282(18):1737–44.
33. Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing
generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):
1092–7.
34. Schecklmann M, Landgrebe M, Langguth B, TRI Database Study Group.
Phenotypic characteristics of hyperacusis in tinnitus. PLoS One. 2014;9(1):
e86944.
35. Khalfa S, Dubal S, Veuillet E, Perez-Diaz F, Jouvent R, Collet L. Psychometric
normalization of a hyperacusis questionnaire. ORL J Otorhinolaryngol Relat
Spec. 2002;64(6):436–42.
36. Newman CW, Weinstein BE, Jacobson GP, Hug GA. Test-retest reliability of
the Hearing Handicap Inventory for Adults. Ear Hear. 1991;12(5):355–7.
37. Tegg-Quinn S, Bennett RJ, Eikelboom RH, Baguley DM. The impact of tinnitus
upon cognition in adults: a systematic review. Int J Audiol. 2016;55(10):533–40.
38. Broadbent DE, Cooper PF, FitzGerald P, Parkes KR. The Cognitive Failures
Questionnaire (CFQ) and its correlates. Br J Clin Psychol. 1982;21(1):1–16.
39. Diener E, Emmons RA, Larsen RJ, Griffin S. The Satisfaction With Life Scale.
J Pers Assess. 1985;49(1):71–5.
40. Newman CW, Sandridge SA, Bolek L. Development and psychometric
adequacy of the screening version of the Tinnitus Handicap Inventory.
Otol Neurotol. 2008;29(3):276–81.
41. Jasper K, Weise C, Conrad I, Andersson G, Hiller W, Kleinstaeuber M.
Internet-based guided self-help versus group cognitive behavioral therapy
for chronic tinnitus: a randomized controlled trial. Psychother Psychosom.
2014;83(4):234–46.
42. Andersson G, Stromgren T, Strom L, Lyttkens L. Randomized controlled trial
of Internet-based cognitive behavior therapy for distress associated with
tinnitus. Psychosom Med. 2002;64(5):810–6.
43. UK Parliament. Data Protection Act. 1998. http://www.legislation.gov.uk/
ukpga/1998/29/contents. Accessed 10 Apr 2017.
Beukes et al. Trials  (2017) 18:186 Page 10 of 11
44. Riach E. The Privacy and Electronic Communications Directive. New Law J.
2003;1(7071):379–80.
45. Piaggio G, Elbourne DR, Altman DG, Pocock SJ, Evans SJ, Consort Group.
Reporting of noninferiority and equivalence randomized trials: an extension
of the CONSORT statement. JAMA. 2006;295(10):1152–60.
46. IBM SPSS Statistics for Windows version 20.0. Armonk: IBM; 2011.
47. Fackrell K, Hall DA, Barry JG, Hoare DJ. Psychometric properties of the
Tinnitus Functional Index (TFI): assessment in a UK research volunteer
population. Hear Res. 2016;335:220–35.
48. Flight L, Julious SA. Practical guide to sample size calculations: an
introduction. Pharm Stat. 2016;15(1):68–74.
49. Yoo B. Impact of missing data on type 1 error rates in non‐inferiority trials.
Pharm Stat. 2010;9(2):87–99.
50. Little RJA. A test of missing completely at random for multivariate data with
missing values. J Am Stat Assoc. 1988;83(404):1198–202.
51. Asendorpf JB, Van De Schoot R, Denissen JJ, Hutteman R. Reducing bias
due to systematic attrition in longitudinal studies: The benefits of multiple
imputation. Int J Behav Dev. 2014;38(5):453–60.
52 NVivo qualitative data analysis software version 9. Melbourne: QSR
International Pty Ltd.; 2006.
53 Krippendorff K. Content analysis: an introduction to its methodology. 3rd
ed. Thousand Oaks: Sage; 2013.
54 Musiat P, Goldstone P, Tarrier N. Understanding the acceptability of e-
mental health –attitudes and expectations towards computerised self-help
treatments for mental health problems. BMC Psychiatry. 2014;14:109.
55 Office for National Statistics. Internet access: households and individuals.
London: Her Majesty’s Stationary Office; 2016.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Beukes et al. Trials  (2017) 18:186 Page 11 of 11
